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DNA complementary to mRNA extracted from the thyroid glands of patients suffering from medullary 
carcinoma of the thyroid (MCT), a calcitonin-producing tumour, was inserted in the Pst site of pBR 322 
by G-C tailing. The recombinant plasmids were used to transform Escherichia cob DP 50. Ampicillin- 
resistant clones were screened using a ‘*P-labelled cDNA to mRNA extracted from a case of MCT 
particularly rich in calcitonin (CT) mRNA. Positive clones were subsequently rescreened using a 32P 
poly(T) probe. Eighty clones were thus purified, and the inserts obtained by digestion with PstI were 
subjected to positive hybridization selection with subsequent ranslation in vitro. An insert stimulating 
synthesis of the protein and containing restriction sites compatible with the previously published complete 
sequence of calcitonin mRNA from rat was sequenced. This cDNA insert contained the entire coding 
region of 426 bp, 70 bp at the .5’-end, and 295 bp upstream from the poly(A) tail. The complete amino 
acid sequence of human preprocalcitonin could thus be deduced. 
Preprocalcitonin mRNA Medullary carcinoma of the thyroid 
N-terminal peptide 
Cloning Complete sequence 
1. INTRODUCTION 
Calcitonin (CT), the hypocalcemic hypophos- 
phatemic hormone [1,2], is the specific marker for 
medullary carcinoma of the thyroid (MCT) [3] a 
tumor existing either in sporadic or familial 
(autosomal dominant) form. The hormone is also 
produced ectopically by a large number of tumors 
thought to arise from cells sharing either common 
histochemical characteristics, the Apud concept 
[4], or the same embryological origin, the neural 
crest [5]. Establishing the structure of the calci- 
tonin gene in normal and pathological conditions 
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and producing specific probes are of importance for 
studying the different forms of MCT, sporadic or 
hereditary, and in demonstrating the ectopic pro- 
duction of the hormone in other types of cancer. 
The presence of a prohormone with an approx- 
imate M, of 11800 has been reported [6]. Transla- 
tion of mRNA extracted from MCT in cell-free 
systems has resulted in the synthesis of primary 
translation products of similar M,, 15000 [7] and 
14500 [8], or in products with higher M,, 21000 
[9]. An M, of 55 000 was initially reported in [lo] 
using an intact cell for translation, the frog pocyte. 
A partial nucleotide sequence of human CT 
mRNA, extracted from a case of familial MCT 
and coding for a 21 kDa translation product, has 
recently been reported [ll]. We report here the 
complete nucleotide sequence of cDNA to human 
calcitonin mRNA extracted from a case of spor- 
adic MCT. This mRNA directs the translation of 
14.5 kDa preprocalcitonin. 
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2. MATERIALS AND METHODS 
2.1. Extraction of poly(A)-rich RNA 
Total cytoplasmic RNA was extracted from 
thyroid glands removed from several patients suf- 
fering from medullary carcinoma of the thyroid 
(MCT) using phenol chloroform extraction. Po- 
ly(A)-rich RNA was isolated by chromatography 
on oligo(dT) cellulose. 
2.2. Synthesis of dscDNA 
Total poly(A) RNA was used as a template for 
reverse transcriptase for the synthesis of sscDNA. 
After alkaline hydrolysis the second strand was 
synthesized using the same enzyme. The hairpin 
structure was removed by the action of Sl 
nuclease. After size selection of dscDNA by 
ultracentrifugation, dC tails were added using ter- 
minal deoxynucleotidyl transferase. pBR 322 was 
linearised by the action of PstI and tailed with dG. 
dscDNA were annealed to poly(dC)-tailed pBR 322 
and the resulting chimeric plasmids used to 
transform E. coli strain DP50 under category II 
physical containment conditions. Ampicillin sen- 
sitive clones were screened using a 32P-labelled 
cDNA to poly(A) RNA extracted from another 
case of MCT rich in calcitonin (20% abundance of 
CT mRNA as estimated by translation and specific 
immunoprecipitation). Colonies showing a 
positive response were further screened with a po- 
ly(T) 32P-labelled probe. Plasmids obtained from 
colonies giving a positive response with both 
probes were screened using positive hybridization 
selection [ 121. 
A clone harboring a plasmid containing an insert 
of approximately 800 bp and specifically retaining 
CT mRNA (fig.1) was subjected to restriction 
analysis in order to compare its digestion pattern 
with that of sequenced rat CT cDNA. We have 
designated this plasmid 327 1. 
2.3. Determination of nucleotide sequence 
Restriction fragments suitable for sequence 
Fig. 1. Hybridization selection of calcitonin mRNA by 
cloned cDNA. Recombinant plasmid DNA’s were 
cleaved with PstI, and the inserts were purified by 
polyacrylamide gel electrophoresis and recovered by 
electroelution. DNA was immobilized on nitrocellulose 
filters and hybridized to mRNA. mRNA selectively re- 
tained was eluted from the filters and translated in a 
reticulocyte cell-free system. Labelled translation pro- 
ducts were separated by SDS-polyacrylamide gel elec- 
trophoresis and detected by fluorography performed for 
3 days at - 80°C. Lane a, total translation products im- 
munoprecipitated with anti-human calcitonin antiserum. 
Lane b, C-labelled M, markers, from top to bottom: M, 
30000, carbonic anhydrase; 18 367, lactoglobulin A; 
12 300, cytochrome c; 5700, insulin. Lane C, eluted and 
translated mRNA hybridized to DNA from plasmid 
3271. 
analysis were generated by digestion with the 
restriction endonucleases AvaII, Bg/II, CfoI, 
DdeI, EcoRII, HinfI, HpaII, PstI, RsaI, SacI, 
SphI. They were either 5 ‘-end labelled by 
- 
Fig. 2. Nucleotide sequence of human calcitonin precursor mRNA cloned in plasmid 3271. The figure gives the entire 
nucleotide sequence of human calcitonin precursor and its 3 ‘- and 5’.-flanking regions. The amino acid sequence de- 
duced from the nucleotide sequence is indicated above. Below are listed nucleotides and corresponding amino acids of 
rat preprocalcitonin [15] which differ from the human sequence. Homology between the two sequences was optimized 
by introducing a limited number of gaps (- - -). Numbers above the human protein sequence refer to amino acid posi- 
tions: - 1 to - 84 amino terminal cryptic peptide and leader sequence; 1 to 32 calcitonin; 1 to 25 carboxy terminal cryp- 
tic peptide. 
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5'-CJCTGGCTGG ACGCCGCCGC CGCCGCTGCC ACCGCCTCTG ATCCAAGCCA CCTCCCGCCA 
--ACCAACC C TGGCT CA TCAG ACC GAT AC T TGTA 
-80 -70 
MeR Gt?y Phe Gtn Lyb Phe SUL P4c1 Phe Leu Ala Leu Se4 1.k Leu Val -- 
GAGAGGJGTC ATG GGC TTC m AAG TTC TCC CCC TTC CTG GCT CTC AGC ATC TTG GTC 
G CA T TG T T G C 
Lcu Vd Vd LUl 
-60 -50 
Leu Lerc Gin Ala Gey Seh Leu tt,i~ ACa Ala P4o Phe A4g Se4 Ala Leu G& Se4 Se4 
CTG TTG CAG GCA GGC AGC CTC CAT GCA GCA CCA TTC AGG TCT GCC CTG GAG AGC AGC 
AC T G G TT T G AA TA A 
Ty7 Cyn Gly GLn Vd Leu Thh 
-40 
P&o Ala Ao P40 Ala Th/z Leu Se,4 Gk Ac~3 Glu Ala A42trg Lcu Leu Leu Ata Ala Leu 
CCA GCA G C CCG GCC ACG CTC AGT GAG G C GAA GCG CGC CTC CTG CTG GCT GCA CTG -7F- 7?- 
GC ATG --- T A A T A --- 
Gl,/ MQR: --- GkZu --- 
-30 -20 
VuY GPO 9 Ty4 VaR GLn Me.t Lycs A.&x Se4 G& Lcu GCu G&I Gtu --- --- G& Glu -~ 
GTC CAG GAC TAT GTG CAG ATG AAG GCC AGJ GAG CJG GAG CAG GAG --- --- CAA GAG 
A A AT G GAG GAA G 
Ad 11 ikt Val A4g Gtu G&I 
-10 -I fl 
Ax G~I( GCy St4 Se4 Leu Aop .!WL Pto Akg Sot igi 47&j CL/S GC!/ Abn Leu SC,? Tlvz 
AGA GAG GGC JCC AGC CTG GAC AGC CCC s\GA TCJ AAG CGi; JGC i;GJ AAT CTG AGT ACT 
GCJ T T J c C 
IO 20 
Cy6 hlc< Leu G&y Tlti Ty4 Th4 Gin A,5p Phc A~II 11~s Pl~c Hi The Phe Phcl GCII TCvc 
JGC ATG CTG GGC ACA TAC ACG CAG GAC JJC AAC AAG JTJ CAC 4CG JTC CCC CAA ACT 
G AA C C 
L?ll 
30 +I +io 
Ala Il!c Gly Vcd GCy A& P4v GCy Ly4 195 A,q A5p dkt Se,1 SCI A4p Leu GBu A4 
GCA ATT GGG GTT GGA GCA CCT GGA AAG AAA AGG GAJ ATG JCC AGC GAC TTG GAG AG --f 
J C G AG C 
s i' 7 ACn SC7 Tll4 
+20 
A,5p Hi,5 4 P40 H.L, Vu.l Sm hle.f P40 GCII A511 ACcc A51r Stop -- -__ 
i%? CAT CGC CCT m GTT AGC ATG CCC CAG m GCC AAC JAA ACTCCTCCCT TTCCTTCCTA 
A CA CT -_- -__ _-- --- --- JT G G -G CT C TC 
A4n Hin Ty4 ___ ___ ___ ___ ___ P/,c Gly 
ATJTCCCTJC TJGCATCCTT CCTATAACJT GATCCAJGTG GJJJGGJJCC JCJCTGGTGG CJCTTTGGGC 
G A TT A _-___ CT T C 
TGGJATTGGT GGCTTTCCTT GTGGCAGAGG ATGTCTCAAA CTTCAGATGG GAGGAAAGAG AGCAGGACTC 
AT G TA AA A GTAJCJG GAATCTCCAA JGGGTG GA GAA 3' 
ACAGGJTGGA AGAGAATCAC CTGGGAAAAT ACCAGAAAAJ GAGGGCCGCT JJGAGTCCCC CAGAGATGTC 
AJCAGAGCJC CTCTGTCCJG CTTCTGAATG JGCJGAJCAT TJGAGGAAJA AAATTATTTT TCCCC 
poey AlZb) -3'. 
95 
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polynucleotide kinase with [Y-~~P]ATP or 3 ’ -end 
labelled by terminal transferase with 3’-[32P]cor- 
dycepin 5 ’ -triphosphate using a commercial kit 
(NEN). After cleavage with a second restriction en- 
zyme or strand separation, fragments were 
separated by gel electrophoresis and submitted to 
the chemical sequencing reaction in [ 131. 
3. RESULTS AND DISCUSSION 
We report here what is to our knowledge the 
first complete sequence of the primary translation 
product of human calcitonin mRNA, a polypep- 
tide of 141 amino acids. In addition to the 426 bp 
of the coding region, plasmid 3271 contains 70 bp 
in the 5 ’ - and 295 bp in the 3 ’ -untranslated regions 
(fig.2). Almost total agreement in nucleotide se- 
quence was found between this sequence derived 
from mRNA extracted from patients with sporadic 
MCT and the partial sequence, coding for 93 
amino acids but lacking the N-terminal region, 
reported in [l 1] for mRNA extracted from a case 
of hereditary MCT. The only differences noted 
were a substitution of a single nucleotide in the 
triplet coding for leucine (position - 36), where we 
found CTC instead of GTC and consequently 
leucine instead of valine, and the absence of one 
adenine after position 630 in the untranslated 
region. Whether these discrete differences are due 
to genetic polymorphism or to spontaneous muta- 
tions occurring in the course of the malignant 
disease is of potential interest. 
The Mr of the precursor of human calcitonin 
which we deduce from the amino acid sequence, 
15461, is consistent with the Mr of the primary 
translation products of human CT mRNA 
reported by us [8] and in [7], 14500 and 15 000, 
respectively. It is, however, much lower than the 
relative M,, 21000, found in [9] after translation of 
mRNA extracted from a case of familial MCT. 
Since it was this familial MCT mRNA which was 
used to establish the partial nucleotide sequence of 
human calcitonin [ 111, the apparent contradiction 
in protein M, could be due to differences in migra- 
tion rate of the precursors in polyacrylamide gels. 
The reported partial sequence [1 l] is almost iden- 
tical to ours; thus if differences in the proteins ex- 
ist, they should be located in the N-terminal 
region. 
96 
Extensive homology in nucleotide sequence in 
the translated region, and consequently in the 
amino acid sequence, is found with rat CT precur- 
sor [14,15]. However, human preprocalcitonin is 
longer than that of rat by 5 amino acids which are 
located 3 amino acids before the stop codon [ 111. 
This C-terminal peptide also contains 8 amino acid 
substitutions. In both species the N-terminal 
amino acid extensions have the same length (84 
amino acids) but show 21 differences in amino acid 
sequence. 
Leader sequences of human and murine 
preprocalcitonin seem to be of similar length since 
the potential amino acid cleavage site, alanine- 
valine, in murine preprocalcitonin [14] cor- 
responds to alanine-alanine in the human 
molecule. The amino acid substitutions observed 
concern amino acids having similar side functions, 
with the exceptions of leucine for tyrosine and 
glycine for cysteine. In the N-terminal cryptic pep- 
tide also, substitutions involve amino acids with 
similar side functions. However, the N-terminal 
region of human precalcitonin is poorer in 
methionine (-2 residues) and richer in proline 
(+ 1 residue). The total number of acidic amino 
acids is equal in the two molecules. Therefore, it 
would seem that the cryptic N-terminal peptide has 
been more highly conserved than the C-terminal 
cryptic peptide during evolution. 
As for the untranslated regions, a higher fre- 
quency of nucleotide substitutions is found in both 
3 ’ - and 5 ‘-flanking regions as compared with the 
coding region. This difference could be due simply 
to species differences especially in the case of the 
3 ’ -region. In the 5 ’ -region, however, important 
differences are found not only between human and 
murine mRNA, but also intraspecies [14,151. As 
no other sequence of the 5 ’ -untranslated region of 
the human calcitonin mRNA is known, the 
presence or absence of polymorphism and its even- 
tual consequences are still to be determined. 
Screening of a genomic bank with the complete 
cDNA probe and determining the structure of the 
calcitonin gene (in progress) will determine the se- 
quence of the precursor of calcitonin in normal 
tissues as well as eventual modifications of the 5 ‘- 
and 3 ’ -non-coding regions. 
Furthermore, elucidation of the complete se- 
quence of preprocalcitonin will allow development 
of a region-specific radioimmunoassay for detec- 
Volume 167, number 1 FEBS LETTERS February 1984 
ting the N-terminal region of the molecule, as has 
already been achieved for the C-terminal region 
[16]. Such an assay will help in elucidating the 
steps in biosynthesis of the hormone and the role 
of the N-terminal region in this process. 
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